| Maternal immune activation in rats produces temporal perception impairments in adult offspring analogous to those observed in schizophrenia AR Deane, J Millar, DK Bilkey, RD Ward PloS one 12 (11), e0187719, 2017 | 33 | 2017 |
| Occurrence of Rat Lungworm (Angiostrongylus cantonensis) in Invasive Coqui Frogs (Eleutherodactylus coqui) and Other Hosts in Hawaii, USA CN Niebuhr, SI Jarvi, L Kaluna, BL Torres Fischer, AR Deane, ... Journal of wildlife diseases 56 (1), 203-207, 2020 | 16 | 2020 |
| Mitogen-activated protein kinase (MAPK) signalling corresponds with distinct behavioural profiles in a rat model of maternal immune activation AR Deane, N Potemkin, RD Ward Behavioural Brain Research 396, 112876, 2021 | 15 | 2021 |
| Validation of a death assay for Angiostrongylus cantonensis larvae (L3) using propidium iodide in a rat model (Rattus norvegicus) SI Jarvi, J Jacob, RT Sugihara, IL Leinbach, IH Klasner, LM Kaluna, ... Parasitology 146 (11), 1421-1428, 2019 | 15 | 2019 |
| Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease SJ Murray, MP Wellby, GK Barrell, KN Russell, AR Deane, JR Wynyard, ... Frontiers in Pharmacology 14, 1212235, 2023 | 1 | 2023 |
| Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease NL Mitchell, SJ Murray, MP Wellby, GK Barrell, KN Russell, AR Deane, ... Frontiers in Genetics 14, 1212228, 2023 | 1 | 2023 |
| Cognitive and arginine metabolic correlates of temporal dysfunction in the MIA rat model of schizophrenia risk. AR Deane, Y Jing, R Shoorangiz, P Liu, RD Ward Behavioral neuroscience 137 (1), 67, 2023 | 1 | 2023 |
| The instrumental role of operant paradigms in translational psychiatric research: Insights from a maternal immune activation model of schizophrenia risk AR Deane, RD Ward Journal of the Experimental Analysis of Behavior 117 (3), 560-575, 2022 | 1 | 2022 |
| Supplementary Material Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten NL Mitchell, SJ Murray, MP Wellby, GK Barrell, KN Russell, AR Deane, ... | | |
